|
|
||||||||
Ann Thorac Surg 2006;81:542-546
© 2006 The Society of Thoracic Surgeons
a Department of Anesthesia and Intensive Care Medicine, Helsinki University Central Hospital, Helsinki, Finland
b Department of Cardiothoracic Surgery, Helsinki University Central Hospital, Helsinki, Finland
Accepted for publication July 18, 2005.
* Address correspondence to Dr Kuitunen, Department of Anesthesia and Intensive Care Medicine, Helsinki University Hospital, PO Box 340, Helsinki, FIN-00029 HUS, Finland (Email: anne.kuitunen{at}hus.fi).
| Abstract |
|---|
|
|
|---|
METHODS: The 813 consecutive patients undergoing cardiac surgery at Helsinki University Central Hospital were analyzed. According to the RIFLE classification (named by the severity of renal impairment: Risk, Injury, Failure, Loss, End-stage kidney disease) patients were divided into three levels based on either plasma creatine level or urine output.The discrimination with death within 90 days after surgery was determined.
RESULTS: According to the RIFLE criteria, 19.3% of patients had renal impairment after cardiac surgery. Patients in the more severe category, RIFLE-F (failure), had a 90-day mortality rate of 32.5% compared with 8.0% for those in RIFLE-R (risk) and 21.4% for RIFLE-I (injury) patients. The RIFLE classification discriminated 90-day mortality quite well (area under curve 0.824) compared with the change of plasma creatinine and the change of estimated gromerular filtration rate (areas under curve 0.849 and 0.829, respectively). The results of the multivariate forward stepwise logistic regression analysis found that RIFLE classification was an independent risk factor for 90-day mortality (p < 0.0001), unlike change in glomerular filtration rate and change in plasma creatinine.
CONCLUSIONS: We propose that the RIFLE classification is a valuable method to evaluate acute renal failure after cardiac surgery. The severity of RIFLE classification may be associated with increased 90-day mortality rate.
| Introduction |
|---|
|
|
|---|
The observed incidences have been varied depending on many factors, such as the study population, exclusion criteria, and especially criteria for defining renal dysfunction. The spectrum of definitions of ARF has ranges from severe (for example, ARF requiring dialysis) [2, 3] to relatively modest observable increases in serum creatinine concentration [6, 9], or decreases in calculated glomerular filtration rate (GFR) [5]. To optimize the approach to ARF, there is an international demand to the recommendations for the criteria of ARF. The Acute Dialysis Quality Initiative Workgroup has outlined consensus criteria [16]. This classification is divided into three levels based on either plasma creatinine level or urine output. This recommendation for the definition of ARF has not been evaluated in special patient populations. Thus, in the present investigation, we tested this classification of ARF known as RIFLE (for Risk, Injury, Failure, Loss, End-stage kidney disease) postoperatively after cardiac surgical procedures.
| Material and Methods |
|---|
|
|
|---|
Routine computerized data collection consisted plasma creatinine levels and urine outputs during the stay in the cardiac surgical intensive care unit (CareSuite6.3; Picis, Wakefield, Massachusetts). Our laboratory determined plasma values of creatinine instead of serum values, but the values have been evaluated to correspond each other [17]. From obtained values, the classification for ARF by the Acute Dialysis Quality Initiative Workgroup was constructed [16]. This classification has been named RIFLE according the severity of renal impairment (Table 1). According to GFR, plasma creatinine (where change from the patient's individual baseline was measured), and urine output, patients were classified into three severity categories: risk, injury, and failure. The patients with renal replacement therapy (RRT) for renal indications should be considered to have ARF regardless of their plasma creatinine level or urine output. The patients without any injury have been classified as RIFLE0 level.
|
The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is used in many European countries and in all cardiosurgical centers in Finland. The EuroSCORE has been originally validated for the prediction of mortality [19]. The EuroSCORE was entered into a computerized database on the day of operation.
The studied outcome variables were the 90-day mortality and the prolonged stay (5 or more days) in the ICU. Renal replacement therapy was recorded; it was either intermittent hemodialysis or continuous venovenous hemodiafiltration. Any other major morbidity was not evaluated.
Data are presented in medians with interquartile ranges. The Mann-Whitney U test or Pearson
2 test were performed to evaluate differences between survivors and dead patients. The discrimination of each risk factor (RIFLE, change in plasma creatinine, change in GFR, EuroSCORE) was determined and compared by receiver operating characteristic curves for 90-day mortality. With this test, an area under the receiver operating characteristic curve of 1.0 indicates perfect discrimination, whereas an area less than 0.5 means that it is no better than chance. Areas of 0.5 to 0.7 suggest a low predictive discrimination, and values greater than 0.7 confirm the usefulness of the model as a risk predictor [20]. Stepwise multiple logistic regression analyses were performed to determine the independent effect of each factor (RIFLE and type of surgery as category variables; change in plasma creatinine, change in GFR, and EuroSCORE as continuous variables) on 90-day mortality. The SPSS 10.1.3 software (SPSS, Chicago, Illinois) was used in all analyses. For statistics, a p value less than 0.05 was considered significant.
| Results |
|---|
|
|
|---|
The postoperative proportions of 90-day mortality, prolonged stay in the ICU (5 or more days), and renal failure requiring RRT were 4.3% (number of patients, 35 of 813), 17.8% (145 of 813), and 3.2% (26 of 813), respectively. The median postoperative length of stay in ICU for the whole study population was 1 day with interquartile ranges of 1 to 3.
The preoperative EuroSCORE was 5.0 (3.0 to 7.0). The estimated preoperative GFR was 81.8 mL · min1 · 1.73 m2 (67.7 to 98.2 mL · min1 · 1.73 m2), and the lowest postoperative GFR was 85.1 mL · min1 · 1.73 m2 (64.1 to 103.9 mL · min1 · 1.73 m2). The GFR could be estimated in 796 patients preoperatively and in 805 patients postoperatively. The preoperative plasma creatinine level was 81.0 µmol/L (69.0 to 94.0 µmol/L), and the highest postoperative plasma creatinine level was 79.0 µmol/L (65.0 to 100.0 µmol/L). Table 2. shows the number of patients according to the RIFLE classification. The proportions of RRT, 90-day mortality, and prolonged ICU stay (5 or more days) in different RIFLE categories are also presented in Table 2. The RRTs in RIFLE classes 0 and R were not for renal indications. The purpose was to remove fluid overload.
|
|
The results of the multivariate forward stepwise logistic regression analysis found that RIFLE classification was an independent risk factor for 90-day mortality (Exp [B] 2.616, p < 0.001). Change in GFR and change in plasma creatinine level were not independent risk factors for 90-day mortality. The EuroSCORE was also an independent risk factor for 90-day mortality (Exp [B] 1.275, p < 0.001).
The RIFLE criteria include two clinical outcomes: loss and end-stage renal disease. Persistant ARF (loss) is defined as need for RRT for more than 4 weeks (RIFLE class L); whereas end-stage renal disease is defined by need for dialysis more than 3 months (RIFLE class E). In the present study, there were 3 patients requiring RRT more than 4 weeks, and 3 patients requiring RRT more than 3 months.
| Comment |
|---|
|
|
|---|
Postoperative renal dysfunction has been confirmed as one of the most severe complications of cardiac surgery. Furthermore, RRT has markedly increased mortality [2, 3, 9]. The risk of ARF after cardiac surgery has ranged from 5% to 30%, depending on the criteria used to define this complication [1, 2, 410, 12, 21], whereas in 1% to 5% of patients, severe disease requiring RRT develops [1, 2]. In the present study, ARF incidence according to RIFLE classification was 19.3%. The comparison with the previous reports is difficult, as this is the first report evaluating the consensus recommendations for ARF definition in cardiac surgical patients. The mortality rate for ARF has remained high, greater than 50% in most series of patients requiring RRT, despite improvements in intensive care and RRT technology [22, 23]. In the present study, mortality was also increased with ARF. The mortality rate without ARF was 0.9%, whereas the mortality rate with ARF defined as RIFLE class F was 32.5%. Furthermore, the present definition system of ARF had a good association with mortality. That is not so surprising, because both the change in plasma creatinine level and the change in GFR have been previously identified to increase the risk of death [6]. Both of these variables are included in the RIFLE classification.
Because there has been a lack of consensus criteria to define ARF [24], the choice of definition requires discussion. In the context of cardiac surgery, subclinical renal dysfunction, as measured using various makers of renal tubular damage (
1microglobulin, glutathione transferase
, glutathione transferasepi, N-acetyl-ß-D-glucosaminidase), has been described [25]. However, there is no evidence that perioperative increases of these markers are associated with postoperative morbidity or mortality, and thus these surrogate changes can not be used for definition of ARF after cardiac surgery [26]. Generally, plasma concentration of creatinine has been used for definition criteria of ARF. This variable has been used to predict morbidity and mortality after cardiac surgery [46, 9, 1113, 27]. However, different authors have chosen different degrees of abnormality in plasma creatinine levels as cutoffs for diagnosis of ARF. Furthermore, plasma creatinine concentration will not be an accurate reflection of GFR in the nonsteady-state condition of ARF. During the evolution of dysfunction, plasma creatinine will underestimate the degree dysfunction whereas the opposite will be true as renal function recovers. Nonetheless, the degree to which plasma creatinine changes from baseline will reflect the change in glomerular filtration.
Although the kidney has numerous functions, in clinical practice the unique functions of the kidney are both the excretion of waste products of nitrogen metabolism and production of urine. Thus, for clinical research, ARF has to be defined as an abrupt and sustained decrease in glomerular filtration, urine output, or both. Once glomerular filtration has reached a steady state, it can be quantified by measuring 24-hour creatinine clearance or estimate clearance from the plasma concentrations of creatinine. Unfortunately, the accuracy of creatinine clearance is limited because as GFR falls, creatinine secretion is increased, and thus the rise in plasma creatinine is less, resulting in a potentially large overestimation of GFR. Therefore, creatinine clearance represents the upper limit of what the true GFR is under steady-state conditions. Furthermore, as patients with ARF are not in steady state, creatinine clearance will not accurately reflect GFR.
The urine output is a very rarely studied variable in publications concerning ARF after cardiac surgery, although, urine output is more sensitive to changes in renal function than biochemical markers [8]. However, it is far less specific except when severely decreased or absent; the changes in urine output often occur long before biochemical changes are apparent. The new recommendation for the definition of ARF takes account of both renal functions, the excretion of creatinine and the production of urine. The consensus criteria take also into account the patients whose baseline renal function is abnormal before the current insult. In many studies concerning ARF after cardiac surgery, these patients have been excluded from the study material.
These new recommendation for ARF have not yet been widely validated. Thus, we tested the utility of this definition in cardiac surgery, as the renal dysfunction is there still one of the major complications. Postoperative renal failure always causes costs. And despite all these efforts, the clinical outcome is poor, which was also seen in the present study: the deaths and prolonged stay in ICU were directly connected to ARF. These nonspecific clinical endpoints were also chosen in the present evaluation to validate the utility of this new classification, as ARF lacks a gold standard for diagnosis and relatively few survivors go on to end-stage renal failure. Certainly, ARF may serve as an indicator of the severity of disease or associated complications. Nevertheless, several studies have shown that ARF exerts a profound impact on prognosis independent of the severity of the condition [2, 6, 28]. Renal injury itself further increases the risk of developing severe nonrenal complications that may lead to death. Large studies have evaluated the predictive value of classification systems using plasma creatinine or estimated creatinine clearance [6, 11].
The results of the present study confirmed our hypothesis that the association between postoperative ARF defined by new consensus criteria and mortality is strong. Thus, by calculating the RIFLE level, clinicians may identify and consistently classify patients with increased risk of death due to impairment in renal function after cardiac surgery.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Herget-Rosenthal, H. Jakob, and P. Massoudy Risk Factors of Acute Kidney Injury in Chronic Kidney Disease Ann. Thorac. Surg., February 1, 2010; 89(2): 673 - 673. [Full Text] [PDF] |
||||
![]() |
X. Yan, S. Jia, X. Meng, P. Dong, M. Jia, J. Wan, and X. Hou Acute kidney injury in adult postcardiotomy patients with extracorporeal membrane oxygenation: evaluation of the RIFLE classification and the Acute Kidney Injury Network criteria Eur. J. Cardiothorac. Surg., February 1, 2010; 37(2): 334 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zavada, E. Hoste, R. Cartin-Ceba, P. Calzavacca, O. Gajic, G. Clermont, R. Bellomo, J. A. Kellum, and for the AKI6 investigators A comparison of three methods to estimate baseline creatinine for RIFLE classification Nephrol. Dial. Transplant., January 25, 2010; (2010): gfp766v1 - gfp766. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haase, R. Bellomo, G. Matalanis, P. Calzavacca, D. Dragun, and A. Haase-Fielitz A comparison of the RIFLE and Acute Kidney Injury Network classifications for cardiac surgery-associated acute kidney injury: A prospective cohort study J. Thorac. Cardiovasc. Surg., December 1, 2009; 138(6): 1370 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. De Santo, G. Romano, A. Della Corte, V. de Simone, F. Grimaldi, M. Cotrufo, and M. de Feo Preoperative anemia in patients undergoing coronary artery bypass grafting predicts acute kidney injury J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 965 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Chen, X. Ding, and B. Chen Value of the RIFLE classification for acute kidney injury in diffuse proliferative lupus nephritis Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3115 - 3120. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F.L. Later, J. J. Maas, F. H.M. Engbers, M. I.M. Versteegh, E. F. Bruggemans, R. A.E. Dion, and R. J.M. Klautz Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 322 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Albacker, R. Chaturvedi, A. H. Al Kindi, H. Al-Habib, T. Al-Atassi, B. de Varennes, and K. Lachapelle The effect of using microplegia on perioperative morbidity and mortality in elderly patients undergoing cardiac surgery Interactive CardioVascular and Thoracic Surgery, July 1, 2009; 9(1): 56 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Haase-Fielitz, M. Haase, R. Bellomo, G. Lambert, G. Matalanis, D. Story, L. Doolan, B. Buxton, G. Gutteridge, F. C. Luft, et al. Decreased Catecholamine Degradation Associates with Shock and Kidney Injury after Cardiac Surgery J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1393 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Hobson, S. Yavas, M. S. Segal, J. D. Schold, C. G. Tribble, A. J. Layon, and A. Bihorac Acute Kidney Injury Is Associated With Increased Long-Term Mortality After Cardiothoracic Surgery Circulation, May 12, 2009; 119(18): 2444 - 2453. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vanek, J. Snircova, J. Spegar, Z. Straka, J. Horak, and M. Maly Increase in plasma free haemoglobin during cardiopulmonary bypass in heart valve surgery: assessment of renal dysfunction by RIFLE classification Perfusion, May 1, 2009; 24(3): 179 - 183. [Abstract] [PDF] |
||||
![]() |
K. Karkouti, D. N. Wijeysundera, T. M. Yau, J. L. Callum, D. C. Cheng, M. Crowther, J.-Y. Dupuis, S. E. Fremes, B. Kent, C. Laflamme, et al. Acute Kidney Injury After Cardiac Surgery: Focus on Modifiable Risk Factors Circulation, February 3, 2009; 119(4): 495 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Massoudy, S. Wagner, M. Thielmann, U. Herold, E. Kottenberg-Assenmacher, G. Marggraf, A. Kribben, T. Philipp, H. Jakob, and S. Herget-Rosenthal Coronary artery bypass surgery and acute kidney injury--impact of the off-pump technique Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2853 - 2860. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zappitelli, C. R. Parikh, A. Akcan-Arikan, K. K. Washburn, B. S. Moffett, and S. L. Goldstein Ascertainment and Epidemiology of Acute Kidney Injury Varies with Definition Interpretation Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 948 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Dasta, S. L. Kane-Gill, A. J. Durtschi, D. S. Pathak, and J. A. Kellum Costs and outcomes of acute kidney injury (AKI) following cardiac surgery Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1970 - 1974. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bagshaw, C. George, R. Bellomo, and for the ANZICS Database Management Committe A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1569 - 1574. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Waikar, K. D. Liu, and G. M. Chertow Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 844 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bagshaw, C. George, I. Dinu, and R. Bellomo A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1203 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pagano, N. J. Howell, N. Freemantle, D. Cunningham, R. S. Bonser, T. R. Graham, J. Mascaro, S. J. Rooney, I. C. Wilson, R. Cramb, et al. Bleeding in cardiac surgery: The use of aprotinin does not affect survival J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 495 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schetz, I. Vanhorebeek, P. J. Wouters, A. Wilmer, and G. Van den Berghe Tight Blood Glucose Control Is Renoprotective in Critically Ill Patients J. Am. Soc. Nephrol., March 1, 2008; 19(3): 571 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Arnaoutakis, A. Bihorac, T. D. Martin, P. J. Hess Jr, C. T. Klodell, A. A. Ejaz, C. Garvan, C. G. Tribble, and T. M. Beaver RIFLE criteria for acute kidney injury in aortic arch surgery. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1554 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Lin, F.-C. Tsai, Y.-C. Tian, C.-C. Jenq, Y.-C. Chen, J.-T. Fang, and C.-W. Yang Evaluation of Outcome Scoring Systems for Patients on Extracorporeal Membrane Oxygenation Ann. Thorac. Surg., October 1, 2007; 84(4): 1256 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Venkataraman and J. A. Kellum Defining Acute Renal Failure: The RIFLE Criteria J Intensive Care Med, July 1, 2007; 22(4): 187 - 193. [Abstract] [PDF] |
||||
![]() |
D. N. Cruz, I. Bolgan, M. A. Perazella, M. Bonello, M. de Cal, V. Corradi, N. Polanco, C. Ocampo, F. Nalesso, P. Piccinni, et al. North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): Targeting the Problem with the RIFLE Criteria Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 418 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shehabi, A. Ristikankare, T. Kuitunen, A. Kuitunen, L. Uotila, A. Vento, R. Suojaranta-Ylinen, M. Salmenpera, and R. Poyhia Renal protection by N-acetylcysteine Br. J. Anaesth., February 1, 2007; 98(2): 270 - 271. [Full Text] [PDF] |
||||
![]() |
J. A. Lopes, S. Jorge, F. C. Neves, M. Caneira, A. G. da Costa, A. C. Ferreira, and M. M. Prata An assessment of the rifle criteria for acute renal failure in severely burned patients Nephrol. Dial. Transplant., January 1, 2007; 22(1): 285 - 285. [Full Text] [PDF] |
||||
![]() |
W. Van Biesen, R. Vanholder, and N. Lameire Defining Acute Renal Failure: RIFLE and Beyond Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1314 - 1319. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |